HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

advanced glycation end products-bovine serum albumin

GEPA-BSA exerts a potent angiogenic effect on human umbilical cord vein endothelial cells in culture by stimulating their migration & tube formation
Also Known As:
AGE-BSA; BSA-AGE; GEPA-BSA; glycosylation end products, advanced-bovine serum albumin
Networked: 35 relevant articles (0 outcomes, 5 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Franke, Sybille: 2 articles (01/2011 - 07/2008)
2. Wolf, Gunter: 2 articles (01/2011 - 07/2008)
3. Bondeva, Tzvetanka: 2 articles (01/2011 - 07/2008)
4. Wang, Xin-Ling: 1 article (06/2015)
5. Wang, Wei: 1 article (06/2015)
6. Meng, Nan: 1 article (06/2015)
7. Li, Xue-Jiao: 1 article (06/2015)
8. Yan, Qi-Chang: 1 article (06/2015)
9. Luo, Ya-Hong: 1 article (06/2015)
10. Yu, Tao: 1 article (06/2015)

Related Diseases

1. Hypertension (High Blood Pressure)
2. Diabetic Nephropathies (Diabetic Nephropathy)
3. Neuroblastoma
4. Hyperplasia
5. Renal Cell Carcinoma (Grawitz Tumor)

Related Drugs and Biologics

1. Bovine Serum Albumin
2. Serum Albumin
3. Glutathione (Reduced Glutathione)
4. Glucose (Dextrose)
5. Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)
6. Amyloid (Amyloid Fibrils)
7. glycosylated serum albumin
8. Advanced Glycosylation End Products
9. Carbon Monoxide
10. Neutralizing Antibodies

Related Therapies and Procedures

1. Radiotherapy
2. Drug Therapy (Chemotherapy)